Analisis Keuangan Saham PMN - ProMIS Neurosciences, Inc. (NasdaqCM) Stock

ProMIS Neurosciences, Inc.
US ˙ NasdaqCM ˙ CA74346M4065

Gambaran Umum
ProMIS Neurosciences, Inc., based in Canada, operates principally in the biotechnology sector, focusing on discovering and developing precision medicine therapeutics aimed at effectively treating neurodegenerative diseases, particularly Alzheimer’s disease and amyotrophic lateral sclerosis (ALS). Leveraging its proprietary discovery platform, ProMIS is adept at identifying novel therapeutic targets and generating antibodies specifically tailored to these targets. Key projects include its advanced antibody Therapeutics for Alzheimer’s disease, which focus on misfolded strains of Amyloid beta, a pivotal pathological marker of the disease. Furthermore, their extended portfolio explores potential treatments for other neurodegenerative diseases, demonstrating ProMIS Neurosciences' commitment to addressing critical unmet medical needs within the neurological disease domain.
Skor Kualitas, Nilai, dan Momentum

Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.

Kualitas

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Nilai

Model penilaian eksklusif yang memberi peringkat pada perusahaan berdasarkan valuasi relatifnya. Skor berkisar antara 0 hingga 100, dengan 100 sebagai yang paling diremehkan nilainya.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Sentimen Dana

Skor Sentimen Dana (sebelumnya dikenal sebagai Skor Kepemilikan) adalah model kuantitatif eksklusif yang memberi peringkat pada perusahaan berdasarkan tingkat akumulasi kepemilikan.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
  • Nilai operating income untuk ProMIS Neurosciences, Inc. per 2025 Jun 30 adalah -24.58 MM.
  • Nilai net income untuk ProMIS Neurosciences, Inc. per 2025 Jun 30 adalah -8.43 MM.
Period End (TTM) Revenue (MM) Operating Income (MM) Net Income (MM)
2025-06-30 -24.58 -8.43
2025-03-31 -17.11 -0.93
2024-12-31 -13.33 2.78
2024-09-30 -14.70 -0.56
2024-06-30 -11.18 -12.20
2024-03-31 -12.17 -11.89
2023-12-31 -13.46 -13.21
2023-09-30 -18.11 -16.90
2023-06-30 -23.05 -20.49
2023-03-31 -23.11 -20.93
2022-12-31 -22.08 -18.06
2022-09-30 -18.10 -13.04
2022-06-30 -14.32 -8.30
2022-03-31 -11.66 -5.78
2021-12-31 -8.29 -9.79
2021-09-30 0.00 -4.29 -8.09
2021-06-30 0.00 -3.49 -8.15
2021-03-31 0.00 -3.67 -9.21
2020-12-31 0.00 -5.66 -5.66
2020-09-30 0.00 -6.43 -6.43
Laporan Laba Rugi: EPS
Period End (TTM) Earnings Per Share Basic Earnings Per Share Diluted
2025-06-30
2025-03-31 -0.03 -0.03
2024-12-31 0.11 0.11
2024-09-30 -0.03 -0.02
2024-06-30 -0.68 -0.68
2024-03-31 -0.79 -0.79
2023-12-31 -1.07 -1.07
2023-09-30 -1.78 -1.78
2023-06-30 -2.50 -2.50
2023-03-31 -2.67 -2.67
2022-12-31 -2.41
2022-09-30 -1.81 -1.81
2022-06-30 -1.21 -1.21
2022-03-31 -0.91 -0.91
2021-12-31 -1.69
2021-09-30 -1.54 -1.54
2021-06-30 -1.66 -1.66
2021-03-31 -1.91 -1.91
2020-12-31 -1.19
2020-09-30 -1.40 -1.40
Arus Kas: Operasi, Investasi, Pendanaan
  • Nilai cash from operating activities untuk ProMIS Neurosciences, Inc. per 2025 Jun 30 adalah -24.17 MM.
  • Nilai cash from investing activities untuk ProMIS Neurosciences, Inc. per 2025 Jun 30 adalah -0.00 MM.
  • Nilai kas dari aktivitas pendanaan untuk ProMIS Neurosciences, Inc. per 2025 Jun 30 adalah 27.69 MM.
Period End (TTM) Cash From Operating Activities (MM) Cash From Investing Activities (MM) Cash From Financing Activities (MM)
2025-06-30 -24.17 -0.00 27.69
2025-03-31 -21.82 -0.00 27.69
2024-12-31 -27.18 -0.00 27.88
2024-09-30 -22.23 -0.00 26.90
2024-06-30 -17.93 -0.00 17.94
2024-03-31 -18.57 -0.00 17.94
2023-12-31 -10.84 -0.00 17.75
2023-09-30 -11.64 0.00 24.75
2023-06-30 -13.90 0.00 6.49
2023-03-31 -16.23 0.00 6.49
2022-12-31 -17.03 -0.00 6.49
2022-09-30 -16.53 0.09 0.00
2022-06-30 -14.92 0.09 18.64
2022-03-31 -11.92 0.09 18.65
2021-12-31 -9.31 0.09 25.52
2021-09-30 -6.00 -0.01 26.82
2021-06-30 -3.64 -0.09 8.20
2021-03-31 -3.11 -0.09 9.16
2020-12-31 -4.35 -0.11 3.83
2020-09-30 -4.83 -0.11 4.91
Metrik Penilaian: PE, PriceToBook, PriceToTBV
  • p/libro untuk ProMIS Neurosciences, Inc. pada 2025 Jun 30 adalah 1.67.
  • p/tbv untuk ProMIS Neurosciences, Inc. pada 2025 Jun 30 adalah 1.67.
P/Book
The current closing price divided by the book value per share.
P/TBV
The current price divided by the tangible book value per share.
Period End (TTM) p/e P/Book P/TBV
2025-06-30 1.67 1.67
2025-03-31 3.23 3.23
2024-12-31 4.18 4.18
2024-09-30 -3.23 -17.32 -17.32
2024-06-30 -2.44 376.28 376.28
2024-03-31 5.48 5.49
2023-12-31 -1.29 3.22 3.22
2023-09-30 -1.79 -4.30 -4.29
2023-06-30 -0.88 -2.11 -2.11
2023-03-31 -1.10 -3.72 -3.71
2022-12-31 -0.30 4.83 4.98
2022-09-30 -1.63 26.43 27.24
2022-06-30 -2.52 2.87 2.88
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
  • EBIT/EV untuk ProMIS Neurosciences, Inc. pada 2025 Jun 30 adalah -0.13.
  • EBIT (3 tahun) / EV untuk ProMIS Neurosciences, Inc. pada 2025 Jun 30 adalah -1.50.
Period End (TTM) EBIT/EV EBIT (3y)/EV
2025-06-30 -0.13 -1.50
2025-03-31 -0.29 -5.66
2024-12-31 -0.06 -1.20
2024-09-30 -0.32 -0.35
2024-06-30 -0.45 -0.50
2024-03-31 -0.84 -0.77
2023-12-31 -3.48 -2.63
2023-09-30 -0.58 -0.36
2023-06-30 -1.22 -0.76
2023-03-31 -1.06 -0.67
2022-12-31 29.80 23.34
2022-09-30 -0.58 -0.45
2022-06-30 -0.50 -0.52
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
Efektivitas Manajemen
  • roa untuk ProMIS Neurosciences, Inc. pada 2025 Jun 30 adalah -0.66.
  • roic untuk ProMIS Neurosciences, Inc. pada 2025 Jun 30 adalah -0.10.
  • croic untuk ProMIS Neurosciences, Inc. pada 2025 Jun 30 adalah 0.62.
  • ocroic untuk ProMIS Neurosciences, Inc. pada 2025 Jun 30 adalah -2.30.
Period End (TTM) ROA ROE ROIC (Tingkat Pengembalian Investasi Modal) CROIC OCROIC
2025-06-30 -0.66 -0.10 0.62 -2.30
2025-03-31 -0.16 -7.31 -0.08 0.64 -3.06
2024-12-31 -0.04 -0.15 -0.08 0.64 -3.06
2024-09-30 -0.68 -1.81
2024-06-30 -2.68 -154.19 -10.83 -240.90
2024-03-31 -2.44 -2.50 1.92 -1.72
2023-12-31 -3.14 -23.15 -2.50 1.92 -1.72
2023-09-30 -2.01 -3.05
2023-06-30 -2.01 -3.05
2023-03-31 -1.16 -4.48
2022-12-31 -0.40 -1.23 -16.22 -25.00 -21.71
2022-09-30 -0.40 -1.23 -2.05 -3.15 -2.74
2022-06-30 -0.98 -0.65 0.26 -1.26
2022-03-31 -0.77 -0.75 0.86 -1.55
2021-12-31 -1.58
2021-09-30 0.00
2021-06-30 -6.59
2021-03-31 -7.31
2020-12-31 -2.73
2020-09-30 -8.49
Gross Margins
Margin Kotor
The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
Margin Keuntungan Bersih
Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
Margin Operasi
Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) Margin Kotor Margin Keuntungan Bersih Margin Operasi
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31 -2,340.17 -2,768.83 -3,362.27
2022-12-31 -1,655.50 -1,565.83 -2,484.61
2022-09-30 -1,655.50 -1,565.83 -2,484.61
2022-06-30 -1,123.33 -950.11 -1,762.75
2022-03-31 -558.63 -466.08 -902.62
2021-12-31 -607.10 0.00 -1,014.22
2021-09-30 -507.90 0.00 -880.63
2021-06-30 -11,574.66 -45,707.29 -18,969.26
2021-03-31 -1,534.77 -7,348.17 -2,864.55
2020-12-31 -1,780.28 -3,168.66 -3,168.66
2020-09-30 -1,370.58 -2,323.67 -2,323.67
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK)1374339
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations
Other Listings
DE:23J0 € 0.34
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista